Johnson Financial Group Inc (Wisconsin)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
JT
Johnson Financial Group Inc (Wisconsin)'s UTHR Position: Q2 2026 in Review
Johnson Financial Group Inc (Wisconsin) reduced its United Therapeutics (UTHR) stake by 7.5% in Q2 2026, selling an estimated $24.2K and leaving 534 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #281.
Johnson Financial Group Inc (Wisconsin) first reported a position in UTHR in Q2 2013 and has held it in 19 quarters since. The position peaked at $416K in Q2 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) held 534 shares of United Therapeutics worth $289K as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) sold 43 United Therapeutics shares in Q2 2026, an estimated $24.2K.
- United Therapeutics made up 0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #281 holding.
- Johnson Financial Group Inc (Wisconsin) first reported a position in United Therapeutics in Q2 2013 and has held it in 19 quarters since.
- Johnson Financial Group Inc (Wisconsin)'s United Therapeutics position peaked at $416K in Q2 2024.
- 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.